We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
Cap. Flow
+$2.18B
Cap. Flow %
18.39%
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$34.6M
2
WDAY icon
Workday
WDAY
+$33.5M
3
FRC
First Republic Bank
FRC
+$31.8M
4
ZTS icon
Zoetis
ZTS
+$31.3M
5
SYF icon
Synchrony
SYF
+$31M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.7M
2
HON icon
Honeywell
HON
+$31.7M
3
IP icon
International Paper
IP
+$30.5M
4
ADM icon
Archer Daniels Midland
ADM
+$23.8M
5
EMR icon
Emerson Electric
EMR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Financials 17.75%
3 Healthcare 12.17%
4 Consumer Discretionary 11.8%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TPC
3076
Tutor Perini Cor
TPC
$5.14B
$186K ﹤0.01%
17,214
-7,266
-30% -$81.4K
MCS icon
3077
Marcus Corp
MCS
$896M
$185K ﹤0.01%
10,477
-10,477
-50% -$184K
QDRO
3078
DELISTED
Quadro Acquisition One Corp. Class A Ordinary Shares
QDRO
$185K ﹤0.01%
+18,927
New +$184K
LUNG icon
3079
Pulmonx
LUNG
$100M
$183K ﹤0.01%
7,358
-24,597
-77% -$635K
VIV icon
3080
Telefônica Brasil
VIV
$18.6B
$183K ﹤0.01%
16,254
-125,328
-89% -$1.2M
KLRS
3081
Kalaris Therapeutics
KLRS
$96.4M
$183K ﹤0.01%
1,182
+255
+28% +$50.9K
MYPS icon
3082
PLAYSTUDIOS Inc
MYPS
$81.1M
$181K ﹤0.01%
37,355
+1,767
+5% +$7.8K
GSQB.U
3083
DELISTED
G Squared Ascend II Inc. Units, each consisting of one Class A ordinary share and one-third of a redeemable Warrant to acquire one Class A ordinary shares
GSQB.U
$179K ﹤0.01%
18,023
-200
-1% -$1.99K
GRWG icon
3084
GrowGeneration
GRWG
$90.1M
$178K ﹤0.01%
19,353
-122,788
-86% -$1.11M
TCRR
3085
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$178K ﹤0.01%
64,511
-34,294
-35% -$108K
GLDD
3086
DELISTED
Great Lakes Dredge & Dock
GLDD
$177K ﹤0.01%
+12,637
New +$182K
SND icon
3087
Smart Sand
SND
$198M
$176K ﹤0.01%
+50,979
New +$134K
LL
3088
DELISTED
LL Flooring Holdings, Inc.
LL
$175K ﹤0.01%
+12,500
New +$191K
DHX icon
3089
DHI Group
DHX
$165M
$174K ﹤0.01%
29,294
+17,403
+146% +$99.7K
PDLB icon
3090
Ponce Financial Group
PDLB
$495M
$174K ﹤0.01%
+16,754
New +$178K
DHAI
3091
DELISTED
DIH Holdings US
DHAI
$173K ﹤0.01%
+702
New +$173K
ARVL
3092
DELISTED
Arrival Ordinary Shares
ARVL
$173K ﹤0.01%
926
-732
-44% -$157K
CRDF icon
3093
Cardiff Oncology
CRDF
$80.9M
$171K ﹤0.01%
69,090
+59,639
+631% +$211K
BRMK
3094
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$170K ﹤0.01%
19,700
+2,942
+18% +$26.2K
BNED icon
3095
Barnes & Noble Education
BNED
$437M
$168K ﹤0.01%
469
-441
-48% -$236K
SES icon
3096
SES AI
SES
$207M
$168K ﹤0.01%
+18,542
New +$140K
FRO icon
3097
Frontline
FRO
$8.51B
$167K ﹤0.01%
18,939
+1,321
+7% +$10.5K
CKPT
3098
DELISTED
Checkpoint Therapeutics
CKPT
$166K ﹤0.01%
9,381
+2,491
+36% +$53.5K
OCUL icon
3099
Ocular Therapeutix
OCUL
$2.12B
$165K ﹤0.01%
33,240
-149,994
-82% -$831K
SOAR.WS
3100
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$165K ﹤0.01%
+589,696
New +$187K
122 123
124
125 126

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.

  • Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
  • Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
  • Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
  • Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
  • Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
  • Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.